Artivion Inc. (AORT)
28.91
-0.45 (-1.53%)
At close: Feb 20, 2025, 3:59 PM
28.82
-0.31%
After-hours: Feb 20, 2025, 06:30 PM EST
undefined% (undefined)
| Bid | 28.1 |
| Market Cap | 1.21B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.03 |
| PE Ratio (ttm) | -963.67 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 29.7 |
| Volume | 272,312 |
| Avg. Volume (20D) | 299,647 |
| Open | 28.89 |
| Previous Close | 29.36 |
| Day's Range | 28.12 - 28.93 |
| 52-Week Range | 18.38 - 32.33 |
| Beta | undefined |
About AORT
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems fo...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 12, 1993
Employees 1,500
Stock Exchange NYSE
Ticker Symbol AORT
Website https://artivion.com
Analyst Forecast
According to 5 analyst ratings, the average rating for AORT stock is "Buy." The 12-month stock price forecast is $32, which is an increase of 10.69% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Artivion Inc. is scheduled to release its earnings on Feb 24, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+12.81%
Artivion shares are trading higher after the compa...
Unlock content with
Pro Subscription
